Reuters logo
BRIEF-Abbott initiates study of AMPLATZER device to correct congenital heart defect in newborns
August 30, 2017 / 4:00 PM / 3 months ago

BRIEF-Abbott initiates study of AMPLATZER device to correct congenital heart defect in newborns

Aug 30 (Reuters) - Abbott Laboratories

* Abbott initiates ground-breaking U.S. pivotal study of AMPLATZER device to correct common congenital heart defect in newborns

* ‍Study of AMPLATZER device​ will enroll approximately 50 patients at up to 10 centers across United States Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below